Semax ischemia research is one of the most extensively documented preclinical and clinical application areas for the peptide, extending the Semax research cluster into stroke recovery and related cerebral ischemia biology. The research has been conducted primarily in Russian laboratories alongside clinical research programs, producing a body of literature that covers both rodent model research and extensive clinical observations.
Semax Ischemia Research: Stroke Recovery Animal Model Studies
Semax · Published April 14, 2026 · Updated May 18, 2026 · 7 min read
Quick Answer
Semax ischemia research examines stroke recovery and BDNF-mediated neuroprotection in rodent middle cerebral artery occlusion and other ischemia models. Studies measure infarct volume, neurological function scores, and neurotrophic biomarkers across standardized stroke recovery research protocols. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- Transcriptomic Evidence From Recent Cerebral Ischemia Models
- Cerebral Ischemia Biology
- Rodent Stroke Model Research
- Clinical Research Context
- BDNF Pathway and Neuroprotection
- Inflammation Modulation in Ischemia
- Long Term Recovery Research
- Intranasal Delivery Advantage
- Research Peptide Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is Semax in research contexts?
+
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment with extended stability via a C-terminal Pro-Gly-Pro tail. It is studied in preclinical models for cognitive endpoints, BDNF and NGF expression, and neuroprotection in cerebral ischemia.
How does Semax support recovery after cerebral ischemia?
+
Semax administration in rodent stroke models promotes BDNF expression, supports neuronal survival in the peri-infarct zone, modulates inflammation, and supports functional recovery on motor and cognitive endpoints when administered acutely or in extended recovery windows.
What stroke models are used in Semax research?
+
Models include middle cerebral artery occlusion (transient or permanent), photothrombotic stroke, and global ischemia paradigms. Endpoints span infarct volume, behavioral recovery (Morris water maze, neurological severity scores), and molecular neuroprotection markers.
Is Semax approved for human use?
+
Glossary
Key terms used in this article.
- ACTH(4-10)
- The 4-10 amino acid fragment of adrenocorticotropic hormone, the natural sequence from which Semax is derived.
- BDNF
- Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
- NGF
- Nerve growth factor, the prototypical neurotrophin essential for peripheral and central neuronal survival and growth.
- Intranasal Delivery
- Administration through the nasal mucosa, used for peptides like Semax to bypass first-pass metabolism and access the CNS.
- Heptapeptide
- A peptide consisting of seven amino acid residues; Semax has the sequence Met-Glu-His-Phe-Pro-Gly-Pro.
- Middle Cerebral Artery Occlusion (MCAO)
- The dominant rodent ischemic stroke model, occluding the MCA to produce focal cerebral ischemia.
- Peri-Infarct Zone
- The brain tissue surrounding the ischemic core where neuroprotective interventions can preserve at-risk neurons.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
